Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald I Abrams

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
BMC Complementary and Alternative Medicine|February 6, 2016
Patients Receiving Integrative Medicine Effectiveness Registry (PRIMIER) of the BraveNet practice-based research network: study protocolJeffery A Dusek, Donald I Abrams, Rhonda Roberts, et al.
AIDS Research and Human Retroviruses|February 1, 2007
Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled studyDonald I Abrams, Starley B Shade, Paul Couey, et al.
AIDS (London, England)|September 7, 2012
Exposure to antiretroviral therapy and risk of cancer in HIV-infected personsChun Chao, Wendy A Leyden, Lanfang Xu, et al.
AIDS (London, England)|August 28, 2007
Risk of cancers during interrupted antiretroviral therapy in the SMART studyMichael J Silverberg, Jacqueline Neuhaus, Mark Bower, et al.
AIDS (London, England)|September 11, 2015
Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survivalChun Chao, Lanfang Xu, Michael J Silverberg, et al.
AIDS (London, England)|April 23, 2008
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionJason V Baker, Grace Peng, Joshua Rapkin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseasesJason V Baker, Grace Peng, Joshua Rapkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infectionChun Chao, Michael J Silverberg, Lanfang Xu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 2, 2002
Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059Donald I Abrams, Judith D Bebchuk, Eileen T Denning, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 29, 2012
Hematopoietic cell transplant and use of massage for improved symptom management: results from a pilot randomized control trialWolf E Mehling, E Anne Lown, Christopher C Dvorak, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
BMC Complementary and Alternative Medicine|February 6, 2016
Patients Receiving Integrative Medicine Effectiveness Registry (PRIMIER) of the BraveNet practice-based research network: study protocolJeffery A Dusek, Donald I Abrams, Rhonda Roberts, et al.
AIDS Research and Human Retroviruses|February 1, 2007
Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled studyDonald I Abrams, Starley B Shade, Paul Couey, et al.
AIDS (London, England)|September 7, 2012
Exposure to antiretroviral therapy and risk of cancer in HIV-infected personsChun Chao, Wendy A Leyden, Lanfang Xu, et al.
AIDS (London, England)|August 28, 2007
Risk of cancers during interrupted antiretroviral therapy in the SMART studyMichael J Silverberg, Jacqueline Neuhaus, Mark Bower, et al.
AIDS (London, England)|September 11, 2015
Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survivalChun Chao, Lanfang Xu, Michael J Silverberg, et al.
AIDS (London, England)|April 23, 2008
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionJason V Baker, Grace Peng, Joshua Rapkin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseasesJason V Baker, Grace Peng, Joshua Rapkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infectionChun Chao, Michael J Silverberg, Lanfang Xu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 2, 2002
Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059Donald I Abrams, Judith D Bebchuk, Eileen T Denning, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 29, 2012
Hematopoietic cell transplant and use of massage for improved symptom management: results from a pilot randomized control trialWolf E Mehling, E Anne Lown, Christopher C Dvorak, et al.
Pageof 8